Latest news
AXSM Stock Advances On CEO’s Pipeline Claim: One New Drug Filing Yearly Through 2030 - StocktwitsStocktwits · Mon, 10 Aug 2026 23:25:00 GMTASTS Stock Drops After Hours on Q2 Revenue Miss, Wider-Than-Expected Loss, Investor Focus On Future Launches - StocktwitsStocktwits · Mon, 10 Aug 2026 22:03:00 GMTCABA Stock On Track For Best Day In 6 Months After Positive Early Results From Cell Therapy Trial - StocktwitsStocktwits · Sat, 08 Aug 2026 16:44:19 GMTCUE Stock Jumps Over 100% After Hours — What’s Driving The Rally? - StocktwitsStocktwits · Fri, 07 Aug 2026 22:17:26 GMTAmazon’s $12B Investment In Louisiana Data Center Buildout To Create More Jobs - StocktwitsStocktwits · Fri, 07 Aug 2026 18:45:14 GMTAXSM Stock Is Rising Today After Wall Street’s Positive Stance Despite Mixed Q1 – What's Behind The Optimism? - StocktwitsStocktwits · Fri, 07 Aug 2026 13:33:24 GMTAXSM Stock In Spotlight Ahead Of Key FDA Verdict On Alzheimer’s Drug This Week - StocktwitsStocktwits · Fri, 07 Aug 2026 07:23:46 GMTAxsome Therapeutics’ Q4 Numbers Beat Wall Street Expectations: Analyst Sees Over 23% Upside For Stock - StocktwitsStocktwits · Fri, 07 Aug 2026 06:42:28 GMT